Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Loveday

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Journal of Medical Virology|August 1, 1992
A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudineS Kaye, C Loveday, R S Tedder
AIDS (London, England)|March 9, 2000
HIV drug-resistance testing on archived samples to help current clinical decisionsG L Dean, M Fisher, C Loveday
AIDS (London, England)|October 29, 1998
HIV suppression and risk of drug resistance mutationsA N Phillips, C Loveday, M A Johnson
Genitourinary Medicine|June 1, 1991
Sclerosing cholangitis rapidly following anti-HIV-1 seroconversionD E Mercey, C Loveday, R F Miller
Genitourinary Medicine|August 1, 1992
Transmission of HIV-1 infection by oroanal intercourseS K Gill, C Loveday, R J Gilson
Sexually Transmitted Infections|August 17, 1999
The use of HIV resistance assays--random or randomised?C Loveday, D Dunn, S McCormack, et al.
Journal of Medical Virology|September 1, 1991
Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapyM Semple, C Loveday, I Weller, et al.
AIDS (London, England)|April 15, 1999
High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient populationC Loveday, H Devereux, L Huckett, et al.
AIDS Research and Human Retroviruses|October 1, 1995
The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNAS Kaye, E Comber, M Tenant-Flowers, et al.
AIDS (London, England)|November 8, 2001
Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance developmentA N Phillips, M Youle, M Johnson, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Journal of Medical Virology|August 1, 1992
A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudineS Kaye, C Loveday, R S Tedder
AIDS (London, England)|March 9, 2000
HIV drug-resistance testing on archived samples to help current clinical decisionsG L Dean, M Fisher, C Loveday
AIDS (London, England)|October 29, 1998
HIV suppression and risk of drug resistance mutationsA N Phillips, C Loveday, M A Johnson
Genitourinary Medicine|June 1, 1991
Sclerosing cholangitis rapidly following anti-HIV-1 seroconversionD E Mercey, C Loveday, R F Miller
Genitourinary Medicine|August 1, 1992
Transmission of HIV-1 infection by oroanal intercourseS K Gill, C Loveday, R J Gilson
Sexually Transmitted Infections|August 17, 1999
The use of HIV resistance assays--random or randomised?C Loveday, D Dunn, S McCormack, et al.
Journal of Medical Virology|September 1, 1991
Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapyM Semple, C Loveday, I Weller, et al.
AIDS (London, England)|April 15, 1999
High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient populationC Loveday, H Devereux, L Huckett, et al.
AIDS Research and Human Retroviruses|October 1, 1995
The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNAS Kaye, E Comber, M Tenant-Flowers, et al.
AIDS (London, England)|November 8, 2001
Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance developmentA N Phillips, M Youle, M Johnson, et al.
Pageof 11